# The strategic use of embolization in treating infantile fibrosarcoma-related heart failure: a case report

**Authors:** M. E. Bartoli, G. Cassanelli, G. L. Natali

PMC · DOI: 10.3389/fsurg.2025.1638718 · Frontiers in Surgery · 2025-10-30

## TL;DR

This case report describes a novel endovascular treatment for heart failure caused by a rare infant tumor, showing it can be safer and effective than surgery.

## Contribution

The paper presents the first known use of embolization to treat heart failure caused by a hypervascularized retroperitoneal infantile fibrosarcoma.

## Key findings

- Endovascular embolization improved heart failure symptoms and ultrasound markers in a 2-month-old with retroperitoneal fibrosarcoma.
- The procedure was well tolerated and avoided the risks of surgery in this complex case.
- This approach is recommended for similar cases due to its safety and effectiveness when performed by experienced teams.

## Abstract

Infantile fibrosarcoma (IFS) represents the most common non-rhabdomyosarcoma soft tissue tumor, with 80% of diagnoses under the first year of life. In contrast with adult fibrosarcoma, IFS has lower risks of metastasis, better long-term survival rate, and higher chemosensitivity. Conservative surgery, in association with chemoradiotherapy in case of metastasis or recurrence, usually represents the gold standard treatment.

We examined the case of a 2-month-old female patient affected by retroperitoneal congenital fibrosarcoma, which had caused high-flow heart failure (HFHF) due to its hypervascularization and multiple arteriovenous fistulas. Given the complexity of the case and its atypical vascularization, after multidisciplinary discussion, we decided to perform an endovascular approach rather than a surgical one, aiming to interrupt pathological flow to this abdominal mass. The procedure was well tolerated with fast improvement in both clinical and ultrasound markers of heart failure.

This is the first instance of arteriographic application for the management of HFHF caused by hypervascularized retroperitoneal IFS that we are aware of. In conclusion, we advise using this approach because of its safety and effectiveness, even though it necessitates a high level of experience.

## Linked entities

- **Diseases:** infantile fibrosarcoma (MONDO:0004557), heart failure (MONDO:0005252)

## Full-text entities

- **Diseases:** non-rhabdomyosarcoma soft tissue tumor (MESH:D012983), arteriovenous (MESH:D001165), IFS (MESH:D005354), abdominal mass (MESH:D000007), HFHF (MESH:D006333), metastasis (MESH:D009362)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12611841/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12611841/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12611841/full.md

---
Source: https://tomesphere.com/paper/PMC12611841